Status:
RECRUITING
Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
Lead Sponsor:
Jiapeng Huang
Conditions:
Pulmonary Hypertension
Metal Poison
Eligibility:
All Genders
18+ years
Brief Summary
Investigators plan to recruit 50 PAH patients from UofL PAH Clinic, with various degrees of severity (25 intermediate risk patients and 20 high risk patients) and 10 age and gender matched controls. P...
Detailed Description
Exposures to heavy metals such arsenic, lead, cadmium have been linked to increased incidence of cardiovascular disease (CVD). However, current studies suffer from multiple drawbacks, most studies wer...
Eligibility Criteria
Inclusion
- All patients with the diagnosis of pulmonary hypertension
- Agree to the study protocol
- Healthy volunteers
- Age, gender matched controls
Exclusion
- Younger than 18 years
- Refusal to participate
Key Trial Info
Start Date :
December 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04756076
Start Date
December 2 2020
End Date
December 31 2029
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Louisville Health
Louisville, Kentucky, United States, 40202